SCHEMBL25521679

SCHEMBL25521679

CC(C)c1c(O)cc(-c2ccc3nccnc3c2)cc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR9 Q9NR96 1/20 0.41
▸ TLR8 Q9NR97 1/20 0.41
▸ TLR7 Q9NYK1 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ CASP7 P55210 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TGFBR1 P36897 7/20 0.39
▸ AHR P35869 1/20 0.37
▸ PIK3CD O00329 2/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ HCK P08631 1/20 0.36
▸ SRC P12931 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ PIK3CA P42336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25520064 0.80 TLR8 (0.44) TLR9TLR8TLR7ALDH1A1KDM4E
SCHEMBL25522057 0.80 TGFBR1 (0.40) TLR9TLR8TLR7ALDH1A1KDM4E
SCHEMBL25522432 0.79 NR4A2 (0.45) TLR9TLR8TLR7HSD17B10TGFBR1
SCHEMBL25521410 0.79 RAF1 (0.41) TLR9TLR8TLR7PIK3CA
SCHEMBL25523476 0.77 MAPKAPK2 (0.46) KDR
SCHEMBL25521665 0.76 RPS6KA3 (0.33) AHR
SCHEMBL25523543 0.76 TGFBR1 (0.46) ALDH1A1HPGDHSD17B10TGFBR1EGFR
SCHEMBL8337311 0.75 NPC1 (0.52) TGFBR1HDAC1HDAC6NPC1RAB9A
SCHEMBL21508010 0.75 OGA (0.41) TLR9TLR8TLR7ALDH1A1KDM4E
SCHEMBL25523539 0.74 CYP1A2 (0.42) TLR9TLR8TLR7KDM4EPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 — — WO disclosed
Send feedback